Published in Br Med J (Clin Res Ed) on December 01, 1984
The kidney in rheumatic diseases. Ann Rheum Dis (1989) 1.51
The effects of sulindac and indomethacin on the anti-hypertensive and diuretic action of hydrochlorothiazide in patients with mild to moderate essential hypertension. Br J Clin Pharmacol (1986) 0.91
Effects of indomethacin and sulindac on blood pressure of hypertensive patients. Br Med J (Clin Res Ed) (1986) 0.76
The influence of prostaglandin inhibition by indomethacin on blood pressure and renal function in hypertensive patients treated with cilazapril. Br J Clin Pharmacol (1989) 0.76
Drug toxicity. Ann Rheum Dis (1990) 0.75
Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin. Br Med J (1980) 2.36
Reduction of renal function by newer nonsteroidal anti-inflammatory drugs. Am J Med (1978) 1.96
Effects of sulindac and ibuprofen in patients with chronic glomerular disease. Evidence for the dependence of renal function on prostacyclin. N Engl J Med (1984) 1.65
Arachidonic acid metabolism, prostaglandins and the kidney. Am J Med (1982) 1.30
Interaction between oxprenolol and indomethacin on blood pressure in essential hypertensive patients. Eur J Clin Pharmacol (1982) 1.24
Different interactions of indomethacin and sulindac with thiazides in hypertension. Br Med J (Clin Res Ed) (1982) 1.18
Renal effects of nonsteroidal anti-inflammatory agents. J Lab Clin Med (1983) 1.15
Interaction of conventional and antikaliuretic diuretics with the renal prostaglandin system. Clin Sci (Lond) (1980) 1.08
Volume status as a determinant of the influence of renal PGE on renal function. Nephron (1980) 0.98
The reliability of the measurement of plasma renin activity by radioimmunoassay. Clin Chim Acta (1975) 0.93
Inhibition of the renin-aldosterone response to furosemide by indomethacin. J Clin Endocrinol Metab (1977) 0.93
The effect of oxprenolol and indomethacin on renin and aldosterone of normal subjects during low sodium diet. Eur J Clin Invest (1982) 0.90
Effect of indomethacin on antihypertensive action of captopril in hypertensive patients. Clin Exp Hypertens (1981) 0.88
The effects of indomethacin in treated hypertensive patients. Clin Exp Pharmacol Physiol (1982) 0.85
[Non-steroid anti-inflammatory agents, diuretics and kidney function: a warning]. Schweiz Med Wochenschr (1983) 0.81
Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet (1989) 3.39
Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS (1998) 3.16
Adverse reactions to co-trimoxazole in HIV infection. Lancet (1991) 3.16
Causal or casual? The role of causality assessment in pharmacovigilance. Drug Saf (1997) 2.30
Pharmacokinetics of adjusted-dose lopinavir-ritonavir combined with rifampin in healthy volunteers. Antimicrob Agents Chemother (2004) 2.11
Analysis of variation in plasma concentrations of nelfinavir and its active metabolite M8 in HIV-positive patients. AIDS (2001) 1.94
A Dutch version of the functional index for ankylosing spondylitis: development and validation in a long-term study. Br J Rheumatol (1994) 1.73
A template for improved prevention and control of cardiovascular disease in sub-Saharan Africa. Health Policy Plan (2001) 1.69
Plasma metanephrines in the diagnosis of pheochromocytoma. Ann Intern Med (1995) 1.64
The effects of caffeine on the postprandial fall of blood pressure in the elderly. Age Ageing (1988) 1.54
Arm position is important for blood pressure measurement. J Hum Hypertens (1999) 1.50
IgA serum levels and disease activity in ankylosing spondylitis: a prospective study. Ann Rheum Dis (1985) 1.49
Low plasma concentrations of indinavir are related to virological treatment failure in HIV-1-infected patients on indinavir-containing triple therapy. Antivir Ther (1998) 1.49
Blood pressure patterns and cardiovascular risk factors in rural and urban gambian communities. J Hum Hypertens (2000) 1.46
Dynamic vessel wall properties and their reproducibility in subjects with increased cardiovascular risk. J Hum Hypertens (1998) 1.40
Adrenoceptors on blood cells from patients with primary Raynaud's phenomenon. Clin Sci (Lond) (1991) 1.40
The effect of caffeine on renal vein renin concentration in patients with renal arterial disease. Am J Hypertens (1991) 1.40
Use of diuretics and opportunities for withdrawal in a Dutch nursing home population. Neth J Med (1998) 1.39
[Hypertension and renal artery stenosis; a combination with a difficult diagnosis and treatment]. Ned Tijdschr Geneeskd (1996) 1.39
A patient with abdominal pain and a rash. Neth J Med (2008) 1.39
Withdrawal of antihypertensive drugs in selected patients. Lancet (1994) 1.39
[A single blood pressure reading during check-up for hypertension leads to a change in management more often than multiple readings]. Ned Tijdschr Geneeskd (1994) 1.39
Venous reflux has a limited effect on calf muscle pump dysfunction in post-thrombotic patients. Clin Sci (Lond) (2000) 1.39
[No response to antihypertensive therapy: consider non-adherence]. Ned Tijdschr Geneeskd (2007) 1.39
Sodium-blood pressure interrelationship in pregnancy. J Hum Hypertens (1999) 1.38
[Diagnosis and therapy of hypertension with renal artery stenosis]. Ned Tijdschr Geneeskd (1996) 1.38
[Compliance with therapy: determining factors and possibilities for improvement]. Ned Tijdschr Geneeskd (1994) 1.37
Pharmacovigilance in perspective. Drug Saf (1999) 1.36
[Infection with Mycobacterium genavense in 2 HIV-seropositive patients in Amsterdam]. Ned Tijdschr Geneeskd (1998) 1.35
Principles of signal detection in pharmacovigilance. Drug Saf (1997) 1.31
Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance. J Intern Med (1994) 1.29
Serum concentrations of immunoreactive calcitonin in patients with hypergastrinaemia. Digestion (1980) 1.13
Therapeutic drug monitoring of the HIV protease inhibitor atazanavir in clinical practice. J Antimicrob Chemother (2007) 1.13
Carbamazepine--indinavir interaction causes antiretroviral therapy failure. Ann Pharmacother (2000) 1.13
Characterization of ATP-induced vasodilation in the human forearm vascular bed. Circulation (1994) 1.13
Caffeine and theophylline attenuate adenosine-induced vasodilation in humans. Clin Pharmacol Ther (1990) 1.12
The case for case reports in the Netherlands Journal of Medicine. Neth J Med (2006) 1.10
The captopril test in the detection of renovascular disease in hypertensive patients. Arch Intern Med (1990) 1.10
Thiazide-induced vasodilation in humans is mediated by potassium channel activation. Hypertension (1998) 1.09
Role of the wrist cuff in forearm plethysmography. Clin Sci (Lond) (1991) 1.09
Contribution of inappropriate treatment for hypertension to pathogenesis of stroke in the elderly. Br Med J (Clin Res Ed) (1986) 1.09
Determination of nevirapine, an HIV-1 non-nucleoside reverse transcriptase inhibitor, in human plasma by reversed-phase high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl (2000) 1.08
Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl (1999) 1.07
Radioenzymatic assay of plasma adrenaline and noradrenaline: evidence for a catechol-O-methyltransferase (COMT) inhibiting factor associated with essential hypertension. Clin Chim Acta (1982) 1.05
Evidence for an antagonism between caffeine and adenosine in the human cardiovascular system. J Cardiovasc Pharmacol (1987) 1.05
Comparison of intrabrachial and finger blood pressure in healthy elderly volunteers. Am J Hypertens (1995) 1.05
Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy. INCAS Study Group. AIDS (1999) 1.04
Loose stools during auranofin treatment: clinical study and some pathogenetic possibilities. J Rheumatol (1983) 1.04
Does it matter whether blood pressure measurements are taken with subjects sitting or supine? J Hypertens (1998) 1.03
Pro-inflammatory cytokines in patients with essential hypertension. Eur J Clin Invest (2001) 1.02
Pathogenesis of hypersensitivity reactions to drugs in patients with HIV infection: allergic or toxic? AIDS (1995) 1.02
Randomized trial comparing saquinavir soft gelatin capsules versus indinavir as part of triple therapy (CHEESE study). AIDS (1999) 1.02
Naproxen pharmacokinetics in patients with rheumatoid arthritis during active polyarticular inflammation. Br J Clin Pharmacol (1987) 1.01
The influence of different beta-blocking drugs on the peripheral circulation in Raynaud's phenomenon and in hypertension. J Clin Pharmacol (1992) 1.01
Effect of decaffeinated versus regular coffee on blood pressure. A 12-week, double-blind trial. Hypertension (1989) 1.00
In vivo evidence for K(Ca) channel opening properties of acetazolamide in the human vasculature. Br J Pharmacol (2001) 0.99
Deleterious effects of anabolic steroids on serum lipoproteins, blood pressure, and liver function in amateur body builders. Int J Sports Med (1988) 0.98
Direct vasodilator effects of physiological hyperinsulin-aemia in human skeletal muscle. Eur J Clin Invest (1996) 0.98
Highly sensitive and specific HPLC with fluorometric detection for determination of plasma epinephrine and norepinephrine applied to kinetic studies in humans. Clin Chem (1995) 0.98
Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapy. AIDS (1998) 0.98
A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine. Ann Rheum Dis (1989) 0.97
MRI in patients with suspected vascular parkinsonism. Neurology (1995) 0.97
Comparison of auranofin and aurothioglucose in the treatment of rheumatoid arthritis: a single blind study. Clin Rheumatol (1984) 0.97
Drug use and adverse drug reactions in 105 elderly patients admitted to a general medical ward. Neth J Med (1994) 0.97
Kinetics of (-)125iodocyanopindolol binding to intact human mononuclear cells. J Recept Res (1988) 0.97
Hemodynamic and humoral effects of coffee after beta 1-selective and nonselective beta-blockade. Clin Pharmacol Ther (1983) 0.96
Cardiovascular pharmacology of purines. Clin Sci (Lond) (1997) 0.96
Mechanisms of drug transfer across the human placenta. Pharm World Sci (1998) 0.95
Interaction of sulphonylurea derivatives with vascular ATP-sensitive potassium channels in humans. Diabetologia (1996) 0.94
Effect of low-dose epinephrine infusion on hemodynamics after selective and nonselective beta-blockade in hypertension. Clin Pharmacol Ther (1982) 0.94
The effect of renin-angiotensin system inhibitors on pro- and anti-inflammatory cytokine production. Immunology (1998) 0.93
[Proceedings: Double-blind comparison of MK 231 with indomethacin in spondylitis ankylopoetica]. Ned Tijdschr Geneeskd (1975) 0.93
Association of HLA antigens, toxic reactions and therapeutic response to auranofin and aurothioglucose in patients with rheumatoid arthritis. Tissue Antigens (1983) 0.93
Cross-sectional study of rheumatoid arthritis treatment in a university hospital. Ann Rheum Dis (1985) 0.93
Hemodynamic and neurohumoral effects of various grades of selective adenosine transport inhibition in humans. Implications for its future role in cardioprotection. J Clin Invest (1995) 0.92
The role of epinephrine in the circulatory effects of coffee. Clin Pharmacol Ther (1986) 0.92
The effects of sulindac and indomethacin on the anti-hypertensive and diuretic action of hydrochlorothiazide in patients with mild to moderate essential hypertension. Br J Clin Pharmacol (1986) 0.91
Hemodynamic effects of isometric exercise and mental arithmetic in hypertension treated with selective and nonselective beta-blockade. Clin Pharmacol Ther (1983) 0.91
Influence of selective and non-selective beta-adrenoreceptor blockade on the haemodynamic effect of adrenaline during combined antihypertensive drug therapy. Clin Sci (Lond) (1979) 0.91
Diuretic efficiency of furosemide during continuous administration versus bolus injection in healthy volunteers. Clin Pharmacol Ther (1992) 0.90
Circulatory effects of coffee in relation to the pharmacokinetics of caffeine. Am J Cardiol (1985) 0.90
Skin vascular reactivity in healthy subjects: influence of hormonal status. J Appl Physiol (1985) (1993) 0.90
The effect of a change in ambient temperature on blood pressure in normotensives. J Hum Hypertens (2001) 0.90
Direct vascular effects of furosemide in humans. Circulation (1997) 0.90
Haemodynamic effects of cigarette smoking during chronic selective and non-selective beta-adrenoceptor blockade in patients with hypertension. Br J Clin Pharmacol (1981) 0.89
Endothelin and active renin levels in essential hypertension and hypertension with renal artery stenosis before and after percutaneous transluminal renal angioplasty. J Hypertens (1997) 0.89
Dose-finding study of a once-daily indinavir/ritonavir regimen. J Acquir Immune Defic Syndr (2000) 0.89
Dose-dependent inhibition of the hemodynamic response to dipyridamole by caffeine. Clin Pharmacol Ther (1991) 0.89
Formation and elimination of sulphamethoxazole hydroxylamine after oral administration of sulphamethoxazole. Br J Clin Pharmacol (1994) 0.89
The cardiovascular effects of regular and decaffeinated coffee. Br J Clin Pharmacol (1985) 0.89
Endothelium-dependent vascular relaxation in patients with type I diabetes. Diabetes (1993) 0.89
Geographical variation in prevalence of hypertension within The Gambia. J Hum Hypertens (2001) 0.89
Activation of the sodium-potassium pump contributes to insulin-induced vasodilation in humans. Hypertension (1996) 0.88
Blockade of vascular ATP-sensitive potassium channels reduces the vasodilator response to ischaemia in humans. Diabetologia (1996) 0.88
Insulin stimulates epinephrine release under euglycemic conditions in humans. Metabolism (1998) 0.88
The effect of cholecalciferol supplementation on vitamin D levels and insulin sensitivity is dose related in vitamin D-deficient HIV-1-infected patients. HIV Med (2008) 0.88
Presynaptic inhibition of norepinephrine release from sympathetic nerve endings by endogenous adenosine. Hypertension (1996) 0.88
Could differential virological characteristics account for ongoing viral replication and insidious damage of the brain during HIV 1 infection of the central nervous system? J Clin Virol (2010) 0.87